The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects

Completed · Phase 2 · Has a placebo group

Conditions studied: Dyslipidemia

In brief

The objectives of this study is * To evaluate the efficacy of PRC-4016 by assessment of the percentage change in blood lipids and lipoprotein parameters from baseline after 12 weeks of treatment. * To evaluate the safety of PRC-4016 as assessed by adverse events and other safety parameters

Key facts

Study ID
NCT01893515
Run by
Pronova BioPharma
People needed
87
Starts
2013-07-01
Expected to finish
2014-07-01
Last updated by the study team
2015-10-30

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.